<VariationArchive VariationID="207248" VariationName="NM_001379110.1(SLC9A6):c.370-9_370-5del" VariationType="Deletion" Accession="VCV000207248" Version="12" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-05-01" DateCreated="2016-06-08" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="203985" VariationID="207248">
      <GeneList>
        <Gene Symbol="SLC9A6" FullName="solute carrier family 9 member A6" GeneID="10479" HGNC_ID="HGNC:11079" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="135973837" stop="136047269" display_start="135973837" display_stop="136047269" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135067582" stop="135129427" display_start="135067582" display_stop="135129427" Strand="+" />
          </Location>
          <OMIM>300231</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001379110.1(SLC9A6):c.370-9_370-5del</Name>
      <CanonicalSPDI>NC_000023.11:135998094:TTTATTTTA:TTTA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="135998095" stop="135998099" display_start="135998095" display_stop="135998099" variantLength="5" positionVCF="135998094" referenceAlleleVCF="CTTTAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135080254" stop="135080258" display_start="135080254" display_stop="135080258" variantLength="5" positionVCF="135080253" referenceAlleleVCF="CTTTAT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_001042537.1(SLC9A6):c.526-9_526-5del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.135080258_135080262del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.135080258_135080262del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.135998099_135998103del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.135998099_135998103del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017160.1" sequenceAccession="NG_017160" sequenceVersion="1" change="g.17673_17677del">
            <Expression>NG_017160.1:g.17673_17677del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042537.2" sequenceAccession="NM_001042537" sequenceVersion="2" change="c.526-9_526-5del">
            <Expression>NM_001042537.2:c.526-9_526-5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006359.3" sequenceAccession="NM_006359" sequenceVersion="3" change="c.430-9_430-5del">
            <Expression>NM_006359.3:c.430-9_430-5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379110.1" sequenceAccession="NM_001379110" sequenceVersion="1" change="c.370-9_370-5del" MANESelect="true">
            <Expression>NM_001379110.1:c.370-9_370-5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177651.2" sequenceAccession="NM_001177651" sequenceVersion="2" change="c.370-9_370-5del">
            <Expression>NM_001177651.2:c.370-9_370-5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330652.2" sequenceAccession="NM_001330652" sequenceVersion="2" change="c.274-9_274-5del">
            <Expression>NM_001330652.2:c.274-9_274-5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006359.2" sequenceAccession="NM_006359" sequenceVersion="2" change="c.430-9_430-5delTTTTA">
            <Expression>NM_006359.2:c.430-9_430-5delTTTTA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA318538" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300231.0007" DB="OMIM" />
        <XRef Type="rs" ID="796053290" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.370-9_370-5del AND not specified" Accession="RCV000189417" Version="4">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-05-13" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.370-9_370-5del AND Christianson syndrome" Accession="RCV000240849" Version="12">
        <ClassifiedConditionList TraitSetID="3135">
          <ClassifiedCondition DB="MedGen" ID="C2678194">Christianson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-02-18" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.370-9_370-5del AND Intellectual disability" Accession="RCV000224024" Version="3">
        <ClassifiedConditionList TraitSetID="17021">
          <ClassifiedCondition DB="MedGen" ID="C3714756">Intellectual disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-07-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.370-9_370-5del AND Inborn genetic diseases" Accession="RCV002327019" Version="3">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-18" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2016-06-08" MostRecentSubmission="2024-05-01">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25167861</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27256868</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/db0297b9-0514-429a-a4f0-7933c2cd4d05</URL>
        </Citation>
        <DescriptionHistory Dated="2022-07-07">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-11-06">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-11-06">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="17021" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="22261" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability</ElementValue>
                <XRef ID="HP:0001249" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual developmental disorder</ElementValue>
                <XRef ID="110359009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual functioning disability</ElementValue>
                <XRef ID="228156007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">intellectual disabilities</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MR</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11963" />
                <XRef ID="11963" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Retired, AAN/CNS, 2011">
                <ID Source="PubMed">21956720</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34211152</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">34131312</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2014">
                <ID Source="PubMed">25157020</ID>
              </Citation>
              <XRef ID="C3714756" DB="MedGen" />
              <XRef ID="D008607" DB="MeSH" />
              <XRef ID="MONDO:0001071" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001249" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000730" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001267" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001286" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002122" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002192" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002316" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002382" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002386" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002402" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002458" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002482" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002499" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002543" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003767" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006833" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007154" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007176" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007180" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3135" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5500" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Christianson syndrome</ElementValue>
                <XRef ID="306361" DB="GeneTests" />
                <XRef ID="Christianson+Syndrome/1400" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010278" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MRXS Christianson</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Angelman-like syndrome X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation microcephaly epilepsy and ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation, syndromic, Christianson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC9A6-Related Syndromic Mental Retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0006" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXSCH</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Christianson syndrome (referred to as CS in this GeneReview), an X-linked disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues.</Attribute>
                <XRef ID="NBK475801" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10572" />
                <XRef ID="10572" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334451</ID>
                <ID Source="BookShelf">NBK475801</ID>
              </Citation>
              <XRef ID="85278" DB="Orphanet" />
              <XRef ID="C2678194" DB="MedGen" />
              <XRef ID="MONDO:0010278" DB="MONDO" />
              <XRef Type="MIM" ID="300243" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="530879" SubmissionDate="2015-04-20" DateLastUpdated="2016-06-08" DateCreated="2016-06-08">
        <ClinVarSubmissionID localKey="NM_001042537.1:c.526-9_526-5del|MedGen:C1843367" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000281729" DateUpdated="2016-06-08" DateCreated="2016-06-08" Type="SCV" Version="1" SubmitterName="Diagnostic Laboratory, Strasbourg University Hospital" OrgID="505818" OrganizationCategory="laboratory" OrgAbbreviation="HUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-07-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">submitter's publication</Attribute>
          <Citation>
            <ID Source="PubMed">25167861</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>106</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Hiseq</NamePlatform>
              <TypePlatform>targeted next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">25167861</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>g.135080258_135080262del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001042537.1:c.526-9_526-5del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Intellectual disability</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1843367" Type="CUI" />
          </Trait>
        </TraitSet>
        <StudyDescription>targeted sequencing of 220 intellectual disability genes</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>DI_052016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1153580" SubmissionDate="2017-07-05" DateLastUpdated="2016-09-18" DateCreated="2016-09-18">
        <ClinVarSubmissionID localKey="NM_001042537.1(SLC9A6):c.526-9_526-5del|Mental retardation, X-linked syndromic, Christianson type" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000597126" DateUpdated="2016-09-18" DateCreated="2016-09-18" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001042537.1:c.526-9_526-5del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Mental retardation, X-linked syndromic, Christianson type</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="447809" SubmissionDate="2017-11-28" DateLastUpdated="2016-10-09" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="GDX:58468|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000243056" DateUpdated="2016-10-09" DateCreated="2015-08-07" Type="SCV" Version="10" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The c.430-(9_5)delTTTTA variant has been previously reported (using alternative nomenclature of c.526-9_526-5delTTTTA), as a maternally inherited variant in an male patient (Redin et al., 2014). Several in-silico splice prediction models predict that c.430-(9_5)delTTTTA may damage or even destroy the natural splice acceptor site in intron 2, which may lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006359.2:c.430-9_430-5delTTTTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="580184" SubmissionDate="2021-08-19" DateLastUpdated="2021-08-21" DateCreated="2016-09-18">
        <ClinVarSubmissionID localKey="300231.0007_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" title="SLC9A6, 5-BP DEL, IVS2AS_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" />
        <ClinVarAccession Accession="SCV000299334" DateUpdated="2021-08-21" DateCreated="2016-09-18" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy and his maternal uncle with an attenuated form of Christianson-type X-linked syndromic intellectual developmental disorder (MRXSCH; 300243), Masurel-Paulet et al. (2016) identified a hemizygous 5-bp deletion (c.526-9_526-5del) in intron 2 of the SLC9A6 gene. The mutation was found by targeted sequencing. Analysis of proband cells showed that the mutation led to the production of 4 different transcripts, with 90% of the transcripts resulting in the skipping of exon 3 and an in-frame deletion (Val177_Arg202del) in the fourth transmembrane domain that may affect protein folding within the membrane. The mutation was also found in heterozygous state in the proband's mother and his 3 sisters, all of whom had learning difficulties. Masurel-Paulet et al. (2016) postulated that the milder phenotype in this family may be explained by the residual production of about 10% of the normal transcript.</Attribute>
              <Citation>
                <ID Source="PubMed">27256868</ID>
              </Citation>
              <XRef DB="OMIM" ID="300243" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <Name>SLC9A6, 5-BP DEL, IVS2AS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, IVS2AS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300231.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4970117" SubmissionDate="2022-06-30" DateLastUpdated="2022-07-09" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="db0297b9-0514-429a-a4f0-7933c2cd4d05" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002540693" DateUpdated="2022-07-09" DateCreated="2022-07-09" Type="SCV" Version="1" SubmitterName="ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel" OrgID="508065" OrganizationCategory="consortium" OrgAbbreviation="Rett/AS VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-18">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/db0297b9-0514-429a-a4f0-7933c2cd4d05</URL>
          </Citation>
          <Comment>The c.430-9_430-5del variant in SLC9A6 occurs in the de novo state (biological parentage confirmed) in an individual with delayed motor milestones and hypotonia (Baylor Genetics internal database)(PS2). RNA study has shown that this variant impacts splicing (PMID 27256868) (PS3). This variant has been reported to segregate in four informative meioses (PMID 27256868)(PP1_moderate). The c.430-9_430-5del variant in SLC9A6 has been observed in 2 unrelated families with Christianson syndrome (PMID 27256868, Baylor Genetics internal database) (PS4_supporting). The c.430-9_430-5del variant in SLC9A6 is absent from gnomAD (PM2_supporting). In summary The c.430-9_430-5del variant in SLC9A6 is classified as pathogenic for Christianson syndrome based on the ACMG/AMP criteria (PS2, PS3, PP1_moderate, PS4_supporting, PM2_supporting).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen RettAS ACMG Specifications V2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/bjzrjqbb/clingen_rettas_acmg_specifications_v2.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001042537.1(SLC9A6):c.526-9_526-5del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.135998099_135998103del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010278" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11731976</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7984614" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4979364|MedGen:C2678194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004298990" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27256868</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27256868</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 207248). For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant results in skipping of exon 3, but is expected to preserve the integrity of the reading-frame (PMID: 27256868). This variant is also known as c.526-9_526-5del. This variant has been observed in individual(s) with clinical features of SLC9A6-related conditions (PMID: 27256868). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 2 of the SLC9A6 gene. It does not directly change the encoded amino acid sequence of the SLC9A6 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.135080254_135080258del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2678194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5116592" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a199115|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002630910" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25167861</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27256868</ID>
          </Citation>
          <Comment>The c.430-9_430-5delTTTTA intronic variant, located in intron 2 of the SLC9A6 gene, results from a deletion of 5 nucleotides within intron 2 of the SLC9A6 gene. This variant (described as c.526-9_526-5del) was originally reported in an individual with intellectual disability (Redin C et al. J. Med. Genet., 2014 Nov;51:724-36). In the follow-up study, this individual was described to have mild intellectual disability, microcephaly, and social interaction disabilities, and the same variant was detected in his affected maternal uncle, as well as female family members with learning disabilities and speech difficulties (Masurel-Paulet A et al. Am. J. Med. Genet. A, 2016 Aug;170:2103-10). Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice acceptor site. Analysis of RNA from the proband's blood revealed that the intronic deletion results in the skipping of exon 3 in about 90% of the transcripts, leading to in-frame deletion of 26 amino acids in the TM4 domain (Masurel-Paulet A et al. Am. J. Med. Genet. A, 2016 Aug;170:2103-10). In addition, this variant was not reported in the gnomAD database, with coverage at this position. Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006359.2:c.430-9_430-5delTTTTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="580184" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" MappingRef="Preferred">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="530879" TraitType="Disease" MappingType="Name" MappingValue="Intellectual disability" MappingRef="Preferred">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7984614" TraitType="Disease" MappingType="XRef" MappingValue="C2678194" MappingRef="MedGen">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4970117" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010278" MappingRef="MONDO">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="447809" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5116592" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1153580" TraitType="Disease" MappingType="Name" MappingValue="Mental retardation, X-linked syndromic, Christianson type" MappingRef="Preferred">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

